| Financial Year |
March 31 2023 |
| Monetary Funds |
19,007,840.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,909,517.29 |
| Advances to Suppliers |
1,161,147.65 |
| Other Receivables |
3,644,927.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,112,332.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,804,999.14 |
| Total Current Assets |
52,640,764.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,119,740,000.00 |
| Fixed Assetes |
107,048,437.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,368,946.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
231,829.99 |
| Deferred Income Tax Assets |
833,545.43 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,265,435,762.21 |
| Total Assets |
1,318,076,526.71 |
| Short-Term Loans |
150,922,170.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
125,198,644.39 |
| Accounts Received In Advance |
4,257,476.78 |
| Employee Compensation Payable |
2,984,185.47 |
| Taxes Payable |
24,871,550.99 |
| Interest Payable |
39,876,756.42 |
| Dividend Payable |
1,618,014.13 |
| Other payables |
426,431,092.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
765,080,958.66 |
| Other Current Liabilities |
668,748.96 |
| Sub-Total of Current Liabilities |
1,505,415,395.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,058,051.04 |
| Deferred Income Tax Liabilities |
8,269,472.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,412,696.47 |
| Total Liabilities |
1,537,828,092.04 |
| Paid-In Capital(Or Share Stock) |
231,574,918.00 |
| Capital Surplus |
494,985,950.47 |
| Surplus Reserve |
18,813,049.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,005,957,825.19 |
| Minority Stockholder's Interest |
803,979.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-220,555,544.96 |
| Owner's Equity（Stockholder's Equity） |
-219,751,565.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,318,076,526.71 |
